Lung cancer in never smokers: The role of different risk factors other than tobacco smoking
- PMID: 32062313
- DOI: 10.1016/j.critrevonc.2020.102895
Lung cancer in never smokers: The role of different risk factors other than tobacco smoking
Abstract
Lung cancer (LC), the leading cause of cancer-related deaths worldwide, is a complex and highly heterogeneous disease. Additional to its biological complexity, LC patients are often confronted with a high degree of stigma, mostly from the association of the disease with tobacco. Nonetheless, a proportion of LC patients are never-smokers, a population which we are beginning to comprehensively explore. Several risk factors have been linked to LC in never-smokers. Studies have consistently shown that radon exposure and domestic fuel smoke increase LC risk. Additionally, infections such as Mycobacterium tuberculosis, and Human Papilloma Virus are also risk factors. Other less conclusive associations include inflammatory diseases such as asthma and sarcoidosis. Moreover, we are now aware that molecular characteristics of LC vary widely according to smoking history, with important therapeutic implications. This review comprehensively assesses the current knowledge in terms of risk factors and disease characteristics in the never-smoker lung cancer population.
Keywords: HPV; Never-smoker; Radon; Tobacco; Tuberculosis; Wood-smoke.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest Dr. Cardona reports grants from Merck Sharp & Dohme, Boehringer Ingelheim, Roche, Bristol-Myers Squibb and The Foundation for Clinical and Applied Cancer Research – FICMAC., other from Pfizer, Boehringer Ingelheim, Astra Zeneca, MSD, BMS, Celldex, Roche, personal fees from Merck Sharp & Dohme, Boehringer Ingelheim, Roche, Bristol-Myers Squibb, Pfizer, Novartis, Celldex Therapeutics, Foundation Medicine, Eli Lilly and Foundation for Clinical and Applied Cancer Research – FICMAC, outside the submitted work. Dr. Arrieta reports personal fees from Pfizer, grants and personal fees from Astra zeneca, grants and personal fees from Boehringer Ingelheim, personal fees from Lilly, personal fees from Merck, personal fees from Bristol Myers Squibb, grants and personal fees from Roche, outside the submitted work. All the remaining authors declare no conflict of interest.
Similar articles
-
Association of Smoking in the Home With Lung Cancer Worry, Perceived Risk, and Synergistic Risk.Oncol Nurs Forum. 2017 Mar 1;44(2):E55-E63. doi: 10.1188/17.ONF.E55-E63. Oncol Nurs Forum. 2017. PMID: 28222077 Free PMC article.
-
Residential radon and lung cancer among never-smokers in Sweden.Epidemiology. 2001 Jul;12(4):396-404. doi: 10.1097/00001648-200107000-00009. Epidemiology. 2001. PMID: 11416777
-
[Causes of lung cancer: smoking, environmental tobacco smoke exposure, occupational and environmental exposures and genetic predisposition].Med Clin (Barc). 2007 Mar 17;128(10):390-6. doi: 10.1157/13099973. Med Clin (Barc). 2007. PMID: 17386247 Review. Spanish.
-
Environmental tobacco smoke exposure in women with lung cancer.Lung Cancer. 2004 Feb;43(2):127-34. doi: 10.1016/j.lungcan.2003.08.025. Lung Cancer. 2004. PMID: 14739032
-
Lung cancer in never smokers: clinical epidemiology and environmental risk factors.Clin Cancer Res. 2009 Sep 15;15(18):5626-45. doi: 10.1158/1078-0432.CCR-09-0376. Clin Cancer Res. 2009. PMID: 19755391 Free PMC article. Review.
Cited by
-
Association of immunotoxicological indices with lung cancer biomarkers in poultry, grape, and rose farming workers.Toxicol Res. 2023 Jun 29;39(4):739-747. doi: 10.1007/s43188-023-00199-9. eCollection 2023 Oct. Toxicol Res. 2023. PMID: 37779584 Free PMC article.
-
Identification of Significant Genes in Lung Cancer of Nonsmoking Women via Bioinformatics Analysis.Biomed Res Int. 2021 Oct 11;2021:5516218. doi: 10.1155/2021/5516218. eCollection 2021. Biomed Res Int. 2021. PMID: 34671675 Free PMC article.
-
Rising Canadian and falling Swedish radon gas exposure as a consequence of 20th to 21st century residential build practices.Sci Rep. 2021 Sep 2;11(1):17551. doi: 10.1038/s41598-021-96928-x. Sci Rep. 2021. PMID: 34475435 Free PMC article.
-
APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma.Transl Lung Cancer Res. 2023 Mar 31;12(3):580-593. doi: 10.21037/tlcr-23-150. Transl Lung Cancer Res. 2023. PMID: 37057114 Free PMC article.
-
The relation between epidermal growth factor receptor mutations profiles and smoking patterns in patients with lung adenocarcinoma: A cross-sectional study.Health Sci Rep. 2023 Jul 5;6(7):e1369. doi: 10.1002/hsr2.1369. eCollection 2023 Jul. Health Sci Rep. 2023. PMID: 37425232 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical